Having had a three-month sabbatical working at Fitzpatrick, Jonathan decided to relocate from New Zealand where most recently he'd been Head of the Companion Animal Group at Massey University.
Jonathan said: "My prime passion is working directly with animals and their families in a supportive and exceptional clinical setting. I enjoy pushing boundaries and not accepting the status quo. I want to identify better ways of improving outcomes for patients, and minimising the impact of the disease (or its treatment) on an animal’s quality of life. My sabbatical at Fitzpatrick Referrals exposed me to their tremendous energy and real passion for patient and client care. From the moment the clients walk in the door, I feel there is an embrace that lets people know we truly care and want to do the best for their animal friend. I am looking forward to discovering what we can achieve together. Cancer management is such an important opportunity, with the power to change both animal and human lives positively. The direction and focus of Fitzpatrick Referrals in this area is already incredibly exciting.”
Clinical Director of Oncology and Soft Tissue, Professor Nick Bacon said: "On Jon’s first day of his sabbatical, he jumped right into the team and made an immediate positive impact. He hasn’t looked back. He carries with him such a good energy, which we all absorb and hopefully reflect back. His knowledge of implant design for dealing with defects in the mandible and elsewhere is exceptional and I am looking forward to watching that develop. I am also very pleased that Jon’s wife Sharyn is able to join the team; she is very experienced in the field of advanced imaging in humans, including Fluoroscopy and PET-CT. This is already benefitting our patients as we improve our diagnostic and treatment abilities, and get ready for the future."
Jonathan has active research interests in several clinical areas including soft tissue sarcoma, injection-site sarcoma, endoprosthetics and haemangiosarcoma. He also supports the concept of One Medicine as his PhD research into soft tissue sarcoma, haemangiosarcoma and endoprosthetics has a potential relevance in improving the understanding of treatment paradigms for humans and animals.
The new course is called Veterinary Science: Accelerated Graduate Entry (BVSc), and will welcome its first students in September 2019.
The school says the course responds to calls for innovation in veterinary education while upholding current best practice in adult education to support independent, self-directed, and collaborative learning.
Designed for graduate learners, the programme will see students guided through case-based, tutor-facilitated teaching and learning.
The programme is based on a collaborative approach, where students can work together to gain practical experience from BVS clinics and clinical research.
Students will be taught in new purpose-built teaching facilities at the school in Langford, North Somerset.
The Langford Campus also encompasses equine and small animal hospitals, a dairy farm, diagnostic laboratories, and farm animal, small animal and equine practices.
Professor Richard Hammond, Head of Bristol Veterinary School said: "As someone who was a graduate entry veterinary student myself, I feel passionately about providing opportunities to those who make the choice to train as a vet later in their educational journey.
"This new programme, delivered in purpose built, state-of-the-art facilities will focus on a more student-centred, case-based approach in small groups and with lots of tutor contact and support. We look forward to welcoming our first cohort of students to Bristol in September 2019".
The inquiry in regard to Karen Tracey Hancock took place in her absence in January, after she indicated that she was content not to appear or to be represented.
The charges against Mrs Hancock related to an injury she falsely claimed she sustained to her knee while moving a euthanased dog in August 2015 that was then exacerbated while moving another dog a couple of weeks later.
The charges also stated that she made entries in the practice’s accident book also stating that she had injured her knee at work and then aggravated it later.
The charges also stated that, in County Court civil proceedings against the practice in relation to the alleged injuries, she falsely:
The Committee noted that the County Court claim made by Mrs Hancock was listed for a trial and concluded with a consent order dated 21 June 2019 which stated that the claim was dismissed.
It also considered evidence from eyewitnesses regarding the two alleged events that led to and exacerbated her knee injury in August 2015. In doing so the Committee found that, though Mrs Hancock did have an injury to her right knee, this was due to a horse-riding incident a number of years earlier and that her account of the incidents on 13 and 29 August, and therefore her claims to have been caused injury by them, were false and that her conduct had been dishonest.
The Committee therefore found all charges against Mrs Hancock proven.
The Committee then considered whether the proven charges amounted to serious professional misconduct. In doing so it considered submissions made by Counsel for the RCVS that there were a number of aggravating factors in the case of Mrs Hancock’s conduct including that the misconduct was sustained over a long period of time, was premeditated and involved lying for financial gain.
In commenting on whether the conduct was serious professional misconduct Judith Way, chairing the Committee and speaking on its behalf, said: “The Committee found all of the aggravating factors set out… in this case applied to its decision on whether or not the conduct amounted to disgraceful conduct in a professional respect.
"Such conduct would bring the profession of veterinary nurses into disrepute and would undermine public confidence in the profession because the dishonesty was directly concerned with the respondent’s work as a veterinary nurse in the veterinary practice.
"The Committee concluded that the dishonest behaviour was serious misconduct, particularly so because it took place at the respondent’s workplace. It considered that honesty and trust between veterinary nurses and their employers is essential to the profession and that such conduct as set out in the charges would be considered deplorable by other members of the profession."
The Committee was therefore satisfied that all four charges individually and cumulatively amounted to serious professional misconduct.
Committee members then considered the appropriate sanction for Mrs Hancock, taking into account the aggravating factors, including a lack of insight in that, in correspondence before the hearing, she continued to deny the charges. In mitigation it noted that there had been a significant lapse of time and that she had a long and hitherto unblemished career.
On balance it decided that removal from the Register was the appropriate and proportionate sanction and requested Mrs Hancock be removed from the Register, particularly as dishonesty is considered ‘in the top spectrum of gravity’ for misconduct.
Judith Way added: “The Committee acknowledged that the respondent was physically unwell with her knee between 2015 and 2019. However there was no evidence that her health had caused her to commit the misconduct. It noted the representations that the respondent made regarding the need to support herself financially but the Committee determined that the public interest outweighed the respondent’s own interests in this case because the proven dishonesty in the circumstances in which it took place was fundamentally incompatible with continued professional registration.
“In the Committee’s judgment without any evidence of remorse or insight by the respondent a suspension order could not meet the public interest in this case. It therefore concluded that removal of the Respondent’s name from the register was the proportionate and appropriate sanction in this case.”
Ane’s research interests lie in the surgical correction of neurological diseases leading to chronic pain and epilepsy. Amongst other things, she has developed an international database and phone application to help dogs and owners affected by epilepsy.
Ane began her veterinary studies in her native Spain before transferring to the Veterinary School of Paris (Ecole National Veterinaire d’Alfort) where she completed a three-year European residency in neurology. She then spent eight years working as a neurology-neurosurgery specialist in the UK.
Ane, who speaks five languages, then moved to the USA, where she joined Tufts University, training students, interns and residents and continuing her passion for research.
Henry L'Eplattenier, clinical director at Southfields, said: “We’re absolutely delighted Dr Uriarte has agreed to join the team.
"She is a very talented neurologist with a passion for neuro-oncology and will bring a wealth of experience and knowledge, which will benefit our world-class team."
Ane said: “I’m thrilled for the opportunity of leading the neurology service of such an outstanding hospital.
"Pets are part of our family and having a neurological disorder can be devastation. I’m committed and looking forward to helping referring veterinarians and owners in such circumstances."
The company says it has made the test available in response to customer demand and growing evidence that in rare cases pets living with COVID-19-positive humans can be at risk of infection.
The test will be available to veterinary surgeons in North America this week and will roll out across most of the world in the coming weeks, via the company's worldwide network of laboratories.
Jay Mazelsky, President and Chief Executive Officer of Idexx Laboratories said: "We have continued to monitor the rapidly evolving public health crisis worldwide, paying special attention to the effects on pets.
"While there is currently no evidence that dogs or cats play a role in transmitting the disease to humans, it became clear offering the test was the right thing to do when we saw clinical evidence that pets—especially cats and ferrets—can in rare cases be at risk for infection. And, we heard from our customers around the globe that veterinarians needed a testing option."
Idexx recommends the test is used when three specific criteria are met:
Idexx says leading health authorities agree with the company that transmission of the SARS-CoV-2 virus is primarily person-to-person and advise against testing asymptomatic pets. Since mid-February, the company has tested over 5,000 specimens for the virus, from cats, dogs, and horses with respiratory symptoms in 17 countries. To date, it has found no positive results, suggesting that dogs and cats living with infected people generally remain uninfected, except in rare and isolated cases.
For information about the Idexx SARS-CoV-2 (COVID-19) RealPCR Test for pets, visit idexx.com/covid19-pet-test.
For the study, 2,834 seizure incident cases were identified from a population of 455,553 dogs attending VetCompass participating practices in 2013.
The study found that that approximately 1 in 160 dogs under first opinion veterinary care are affected by seizures every year.
Many of those dogs will have underlying epilepsy, defined as dogs with two or more unprovoked seizures at least 24 hours apart. Seizures can be secondary to idiopathic epilepsy, structural epilepsy or epilepsy of unknown cause.
Until now, however, there has been little information on the classifications of seizures, diagnostic approaches, or clinical management of dogs with seizures in the veterinary first opinion population.
The main findings from the research were:
Dr Dan O’Neill, Senior Lecturer in Companion Animals Epidemiology at the RVC, and author of the paper, said: "Watching your dog undergo a seizure can be an incredibly scary moment for any dog owner. It is really important that dogs that seizure are rapidly diagnosed to decide whether they need no further treatment beyond careful monitoring or alternatively require a clinical work-up to define the cause of the seizures.
"There are now some excellent treatments for many seizure-related diseases. This study helps up to understand the current state of play for seizure management in dogs and identifies opportunities for improved care of these affected dogs."
Reference
The full paper is freely available from Journal of Veterinary Internal Medicine and can be accessed here: https://onlinelibrary.wiley.com/doi/full/10.1111/jvim.15911
Virbac Animal Health has launched Microbex, a POM-V shampoo for the control of Malassezia proliferation and associated clinical signs.
The arrival of Microbex extends the Virbac shampoo range to eight, providing vets with the most comprehensive specialist options in the management of skin conditions, says the company.
Microbex (POM-V) contains 3% chlorhexidine. Product manager Chris Geddes MRCVS said: "Chlorhexidine at this level provides a complete treatment for Malassezia.
"The shampoo also has a flexible application schedule and simple dosing cap, both of which are designed to help improve client compliance and treatment success rate.
Chris added: "Microbex is available in 200ml bottles making it an attractive purchase option for clients."
Further details can be found in the NOAH compendium http://www.noahcompendium.co.uk/. For details on launch promotion contact your local Virbac territory manager or call Virbac on 01359 243243.
Eravac is an injectable emulsion ready for administration without the need for reconstitution beforehand. Containing 10 vials with individual doses, the new presentation is is indicated for the immunisation of pet rabbits from 30 days of age.
For more information, visit: https://www.hipra.com/portal/en/hipra/animalhealth/products/detail/eravac-pets
VetFinders will recruit for permanent and locum positions for veterinary practices throughout the UK, from administration roles through to nursing staff and vets.
The agency has been founded by a man called Chris Worthington who previously built an engineering recruitment firm called Qualtech Resourcing.
Alongside Chris in the VetFinders team are recruiters Gabrielle Dawson and Martin Wilson, both with over 15 years’ experience in recruitment, Chris’s wife Anna, who is charge of accounting and payroll, and administrator Suzy Buttress.
Chris said: "VetFinders is a business with a purpose, a business with a force for good and a business with a double bottom line! Our approach is totally unique in the industry and it’s what sets us apart. Candidates are already hearing about our message and registering with VetFinders rather than other agencies.
"We have chosen four specific charities and our support for them does not stop at the point of donation. We will also be working closely with them, funding specific projects and working on their front line."
The chosen charities are:
Hope Pastures, in Leeds, which rescues, rehabilitates and re-homes horses, ponies and donkeys.
Moorview Rescue in Harrogate, which has re-homed almost 2000 dogs in the UK since it was set up as a registered charity in 2009.
Nuzzlets, a small charity based near Great Ouseburn in York which specialises in giving loving homes to unwanted animals and enabling young people free access to them for therapy and education.
Blue Cross.
When a candidate is placed by VetFinders, the client can choose which of the four charities they want a percentage of their fee to be donated to. The client and placed candidate will then be given regular updates of how their money has benefitted children and animals, including through photos, videos, emails and website updates.
For more information, visit: https://www.vetfinders.co.uk/
Photo: Top (L-R): Martin Wilson - Veterinary Recruitment Consultant, Chris Worthington - Managing Director. Bottom (L-R): Gabrielle Dawson - Veterinary Recruitment Consultant, Anna Worthington - Finance and Payroll Manager and Suzy Buttress - Administrator.
The survey was sent to all UK veterinary practices on the 25th November with a deadline to respond by the 1st December and received 186 responses, a response rate of 6%.
The survey found that during this period:
Lizzie Lockett, RCVS CEO, said: “Thank you once again to all the practice staff who took the time to complete this survey, it really is very useful for us to have a clear picture of how coronavirus and its restrictions are affecting day-to-day activities, as it has an impact both on our decision-making and policies, and what we can tell others about the impact on the professions, such as the UK and national governments.
"The overall picture from this survey is that, while for most it is not business as usual, veterinary practices and members of the professions are, to an extent, getting used to the disruption and have plans and policies in place to help mitigate the impact of the mosaic of different restrictions across the UK.
"While there is hope on the horizon with the start of the roll-out of coronavirus vaccines, we will continue to review and keep up-to-date our advice and guidance to ensure that you can practise to the best of your abilities, while keeping safe and within the rules.
“Of course, we also recognise the toll that the pandemic has taken on many people’s mental health and wellbeing, and this is reflected in some of the more concerning statistics around the impact that staff absences can have on the rest of the team.
"We also asked practices what might help them manage from a staff mental health and wellbeing point of view, and will take these suggestions into account when planning further support via our Mind Matters Initiative mental health project. In the meantime, we would like to remind those who are feeling stressed or are in distress that there are sources of help available during these difficult times – these can be found at www.vetmindmatters.org/help-links/help-during-covid-19/.”
The full report of the survey is available to view at www.rcvs.org.uk/publications
The case was brought by the College after a member of the public raised a 'concern' relating to Mrs Mullen's practice in December 2015. The concern was not pursued by the College.
However, during its initial investigation, the RCVS case manager ascertained that contrary to the requirements of the Code of Professional Conduct, Mrs Mullen did not have PII.
In January 2016 Mrs Mullen was advised by the College that, in order to comply with the Code, she needed to ensure her professional activities were covered by PII or equivalent arrangements.
The matter was considered by the Preliminary Investigation Committee which asked, in October 2016, that Mrs Mullen produce evidence that she was now compliant with the requirement to have PII or equivalent. Mrs Mullen responded in November 2016 confirming that she had not put in place such arrangements.
The case was then referred to the Disciplinary Committee in January 2017.
During the hearing it was determined that, during the relevant time period (from November 2015 to November 2016) Mrs Mullen was practising but did not have professional indemnity insurance in place and therefore was in breach of the Code.
Mrs Mullen, who represented herself, told the Committee that she admitted that she did not have PII. She explained that she was 'ethically and morally opposed to it' as she felt that it did not give fair compensation to claimants and did not know it was a requirement of the Code of Professional Conduct until she was informed by the College in January 2016.
When giving oral evidence as to equivalent arrangements she disclosed that she kept significant funds in a bank account; these were not however specifically earmarked for use in the event of any possible claims, and were also required to pay practice expenses.
In light of evidence produced by the College and her own admissions, the charges against Mrs Mullen were found proved and she was found guilty of disgraceful conduct in a professional respect.
In coming to this decision Chitra Karve, chairing the Committee and speaking on its behalf, said: "The respondent failed to have PII in place for a period of about 12 months as specified in the charges. Moreover, she failed to remedy the situation when advised in January 2016 by the College that she was in breach of the Code and the supporting guidance. This remains a continuous course of conduct, which has still not been remedied. The respondent has chosen not to read the Code, or the supporting guidance, until very recently, in relation to her obligation to have PII or equivalent arrangements in place, and she failed to heed the advice of the College that she must rectify the position."
In considering the sanction the Committee took into account mitigating and aggravating factors. Aggravating factors included the fact that the misconduct was sustained over a significant period of time and that limited insight was shown by Mrs Mullen. While she did begin to display limited insight into the significance of her misconduct, the Committee said that this insight was "hampered by her ambivalence towards the College and the systems that regulate the veterinary profession."
In mitigation the Committee took into account Mrs Mullen’s long and unblemished career and the fact she was a sole practitioner who reported challenging personal circumstances and provided a unique service to a niche group of clients.
However, Chitra Karve said: "The Committee is unable to overlook the Respondent’s lack of commitment to obtaining PII or equivalent arrangements, even after being advised by the College that this was essential. The Committee is aware that a suspension could adversely affect her practice and her clients that she uniquely serves. However the Committee thinks it is necessary to send a clear message to the respondent and the public, that failure to obtain PII or equivalent arrangements is wholly unacceptable."
She added: "Accordingly, the Committee directs the Registrar to suspend the respondent’s registration for a period of two months. The Committee considers that this period of suspension will give the respondent an opportunity to rectify her breaches of the Code in relation to PII… and to reflect upon her attitude towards the College and the appropriate regulation of the veterinary profession."
The pads contain ophytrium and chlorhexidine at 3%. Ophytrium is a purified natural ingredient from Ophiopogon japonicus which, Ceva says, strengthens the mechanical skin barrier1, restores the balance of protective microbial flora2 and reduces irritation, while soothing the skin1. Chlorhexidine is both antibacterial and antifungal.
Ceva says that Douxo S3 Pyo pads, which come in packs of 30, provide antibacterial and antifungal efficacy within one minute and are free from soap, parabens, sulphates, phthalates, colourants and nanoparticles.
They are available in a new, hypoallergenic ‘summertime’ fragrance which pet owners liken to coconut and vanilla.
The pads add to the Douxo S3 Pyo range, which also consists of shampoo and a mousse.
Andrew Fullerton BVSc (Hons) MRCVS, product manager for Douxo S3 at Ceva said: "The new Douxo S3 range has been well received by both veterinary professionals and their clients since its launch, who find that the products are not only effective and well tolerated, but also easy-to-use. The Douxo S3 Pyo pads will enhance this range by offering an easy-to-administer antiseptic action while hydrating and maintaining the skin’s ecosystem.”
For further information, contact cevauk@ceva.com, your local territory manager or visit https://www.douxo.com/uk/Pet-Skin-Care/douxo-s3.
References
The webinar will cover the entire disease process of MMVD in dogs from pathology to current treatment approaches and future advancements in therapy, and will include the following presentations:
https://us06web.zoom.us/webinar/register/WN_QyfUofLgRG-YsaXQbkT7Tw#/registration
The figures came from an analysis of over 100,000 calls made to VidiVet by owners when their normal practice was closed, between 2021 and 2024.
So far in 2024 36% of VidiVet’s calls have been gastrointestinal cases, 25% skin cases, 14% musculoskeletal and 3.7% post-surgical issues.
The advice given to many of these cases was that an emergency visit to an out-of-hours (OOH) clinic wasn’t necessary, but to monitor at home then attend their own vet practice for any workup, diagnostic tests, medication etc.
The company is now encouraging practices to consider using it's triage service over Christmas, when practices and emergency clinics often experience an increase in OOH workload.
This, it says, is a win-win situation as it relieves pressure on OOH clinics, brings revenue back to veterinary practices and also saves clients money, stress and time.
Ben Sweeney, Veterinary Surgeon, CEO and Founder of VidiVet said: “When I launched VidiVet, vet practices were understandably concerned that digital vet services could drive work away from their clinics.
"We hope this new data shows the opposite, and how it can directly benefit practices in a way they might never have imagined.
"What VidiVet has actually done, as was our belief from the get-go, is to drive the bond with clients even closer as well as providing a revenue opportunity for the practice whilst prioritising pet health and welfare.
"This is because the added benefit of a service like ours alleviates part of the immense burden on clinical teams from front of house to the surgical teams, without them losing control.
Kate Higgins MRCVS, owner of Village Vets Crosby & Formby, said: “Over the last six months we’ve saved our clients collectively an estimated £75,000 in emergency vet fees by using VidiVet.
"They were able to be reassured out-of-hours whether their pet did or didn’t need emergency treatment.
"Those that did were able to be treated swiftly by an out-of-hours clinic, and those that did need treatment but not urgently, were able to come to us during our usual working hours, not incurring emergency fees.
"What is even better for us (and our clients) is that we have the case notes from their call with VidiVet ready and waiting for us when we’re open, so we’re up to speed with what the issue has been and what advice has already been given – which is a crucial time saver for both parties.”
www.vidivet.com
Photo: Emma Paine
The ideal Christmas present for a vet to give a child has just landed on my desk.
It's the Amazing ABC Adventure by Lorna Maxwell, out now in paperback from Long Barn Books and available on Amazon here.
Each letter of the alphabet begins an eclectic list of things to be found within a delightful illustration on the facing page. There's a strong animal theme throughout the book: everything from annoyed armadillos and affectionate alligators to worried wombats and yodelling yaks.
One of those books that it's a pleasure to read a child before bed. A steal at £5.79.
The service offers Galen myotherapy, a form of massage, together with diet, exercise, nutraceutical and weight advice, house management advice, and an owner awareness and pain indicator assessment.
Hannah, who spent 14 years in small animal practice, said: "During a very bad week in practice I put two dogs to sleep in quick succession who’d both gone off their back legs. They were mentally there but their bodies had given up. I realised that osteoarthritis needed to be approached much more thoroughly and at a much earlier stage in a dog’s life."
CAM’s home-visiting service assesses arthritic dogs in the calm of their own surroundings. Hannah says that treatment aims to improve a dog’s posture and movement, support their ability to exercise and give owners the tools they need to make life easier for arthritic dogs. She added: "In a consultation, it can be very difficult to get all the information across to an owner whose dog has just been diagnosed with arthritis. CAM is a unique service that fills a gap. It aims to go into a dog’s home and make adjustments that will be good for that individual long-term."
Hannah says that the new service is offered alongside the owner's existing veterinary surgeon, who will need to give consent and prescribe any other treatments, such as NSAIDs, which are needed as part of the larger treatment plan. In other words, it's an additional service that vets can offer to their clients, ensuring they are doing everything they can to help their many arthritic patients.
Hannah said: "Arthritis is a household name, it's massively prevalent in humans and there are huge support services for people dealing with the chronic pain associated with the condition. As a profession we know that dogs with arthritis suffer the same pain – it’s time we had a proper service for them too. CAM is that service – a tailored, multimodal approach to help successfully manage these patients."
Canine Arthritis Management (CAM) is currently available to dog owners throughout Sussex. If you would like to know more, email info@caninearthritis.co.uk
In a European first, Pfizer Animal Health is conducting a major study in over 2000 dogs with Trocoxil, its new NSAID which delivers continuous analgesia for a month.
According to the company, Trocoxil has already been granted a licence by the EMEA and pre-authorization studies have already shown once-monthly Trocoxil to be at least as safe and effective as daily carprofen. However, the monthly dosing regimen represents such a big step from the currently used approach of daily NSAID dosing, that Pfizer has decided to initiate the study before launching the product in order to closely monitor and manage the introduction of Trocoxil to the veterinary market.
Jolian Howell, Associate Director Companion Animal Marketing for Pfizer said: "A drug with such a unique dosing regimen should be introduced in a controlled and managed way, and this study is part of that commitment by Pfizer Animal Health."
This large post-approval study, conducted under veterinary control as a User Experience Study, will enable a similar comparison with carprofen to be made in a much larger patient population. In fact it will be sufficiently large to provide product-specific safety information, such as any differences in the incidence of side-effects.
The randomised, parallel group study is being conducted in more than 100 veterinary clinics throughout France, Germany and the UK. Each dog will receive up to 6 months of treatment during which time it will be assessed every month by the veterinary surgeon.
Trocoxil, a preferential COX-2 inhibitor, has a unique pharmacological profile which means that a single oral dose provides continuous pain relief for a whole month.
Jolian added: "This study will provide veterinary surgeons with an opportunity to experience the benefits of using Trocoxil to treat OA continuously over a period of months. It will also give them the opportunity to assess the benefits this offers the owner."
In addition, less than half of those surveyed knew the correct temperature for vaccine storage, showing there is a lack of knowledge surrounding standard procedures.
Paul Williams, MSD Animal Health UK technical manager for ruminants said: "Failing to maintain the correct fridge storage temperature compromises vaccine effectiveness and consequently animal health.
"In a significant number of farm fridges monitored, the temperature was elevated to 80C for long periods of time, with the maximum fridge temperature recorded being 240C.
"In the worst cases, over 60% of fridges had been at 0 0C or below 0 0C long enough for vital contents to freeze. When the temperature is too high, vaccines become ineffective. If frozen, the vaccine is destroyed.
"This research shows we have work to do in educating customers about how to store vaccines and I encourage all farmers to check their farm fridge temperatures.
"To promote better practice, we’ve launched an awareness campaign called Fridge Check to educate farmers on the importance of storing vaccines correctly.
"The campaign is being promoted by Disease? Not On My Farm!, an initiative helping farmers take a more proactive approach to preventing disease on farm."
To find out more, visit the Disease? Not On My Farm! Facebook and Twitter pages or follow the hashtag #FridgeCheck for more information about how to store vaccines correctly.
There is a need to raise farmers’ awareness of correct vaccine storage temperatures. Williams P. (MSD Animal Health), Paixao G. (University of Bristol).
7,383 veterinary surgeons voted in this year's election, a turnout of 19.7%.
This compares to turnouts of 16.7% in 2023, 18.6% in 2022, 24.5% in 2021, and 26.2% in 2020.
Of the 14 candidates, Professor David Barratt, Sinead Bennett and Zara Kennedy were all elected to serve for a four year term, with 1,747 votes, 1,796 and 2,264 votes respectively.
Mark Bowen (1,404), Richard Brown (1,030), Paddy Gordon (1,612), Gerard Henry (1,157), Peter Higgins (496), Penelope Morgan (1,584), Kate Richards (1,264), Richard Sanderson (1,380), Sally Schroeder (1,630), Lara Wilson (1,399) and the inevitable Thomas Lonsdale (257) were all unsuccessful.
The winning candidates will take up their posts at Royal College Day, which is open to all vets to attend on Friday 5th July at the Royal Institute of British Architects.
www.rcvs.org.uk/vetvote24
The ten-minute online survey aims to gather a snapshot of horse health over the period of a week.
The results help to identify trends in endemic equine diseases and help the Blue Cross steer equine awareness, education and research.
This year the survey includes some welfare questions to help guide knowledge in response to what the charity calls 'the UK’s horse welfare crisis'.
The National Equine Health Survey is run by the Blue Cross in partnership with the British Equine Veterinary Association. Dodson and Horrell is helping to cover the costs of running the scheme.
Supporters of the survey include the British Horse Society, Horse Trust, Redwings and the Pony Club.
Medal-winning riders Mary and Emily King, and Yazmin Pinchen (pictured right) also support the survey.
Visit www.bluecross.org.uk/NEHS or email NEHS@bluecross.org.uk to register and take part, which carries the chance of winning prizes including Star Lister Clippers, a Lister Adagio Trimmer and some Burford Ariat boots.
The company says it has already used part of the funding facility to acquire six practices – four in Wales and two in South London, with the aim to attain many more practices in 2017 across the UK.
Medivet now has 169 veterinary practices across the country, making it the fourth largest veterinary group in the UK.
Will Taylor, Corporate Relationship Manager for HSBC in Thames Valley, said: "It is great to see that Medivet has gone from strength-to-strength over the past few years, with an ambitious business. HSBC has enjoyed a long-standing and highly effective business relationship with Medivet and this latest deal will allow the business to carry out its aspiring acquisition plan and continue to grow at a rapid pace."
Dr Arnold Levy, Chief Executive Officer at Medivet, said: "This latest round of funding will allow us to take up a vast amount of opportunities that have become available to us and accelerate the pace of acquisitions of further practices across the country. Last year we acquired over 50 new sites and this year we plan to attain even more, which is significant progress for our business and testament to our strong financial backing."
The paper was written by FEDIAF’s Scientific Advisory Board, comprised of independent academics from leading European universities, with the aim of informing both the industry and the public.
Based on recent scientific data, the paper explains the different life expectancies of dogs related to their size, and defines when "old age" sets in. It explains how changes in the digestive tract can affect food intake, how food texture may become a crucial factor, and how aging can lead to changes in energy metabolism and alter the nutrient requirements of senior dogs. It also offers practical guidance to pet owners for feeding an older dog.
Dr Thomas Brenten, Chairman of FEDIAF’s Nutrition & Analytical Science Group said: "Age-related changes in cognitive functions, behaviour, skin, digestive tract, cardiovascular system, respiratory tract, degenerative joint and skeletal function, as well as urinary disorders are the most common issues concerning older dogs. Many of these can be addressed via nutrition."
The paper can be downloaded in the new section on science on FEDIAF’s website: https://tinyurl.com/fediaf-senior-dogs.
The company says that Daxocox achieves significant improvement of clinical signs associated with the pain of osteoarthritis (OA) in dogs1,2 and also helps reduce the risk of breakthrough pain.
Breakthrough pain is defined as “an abrupt, short-lived, and intense pain that breaks through the analgesia that controls pain”3. Risk factors for breakthrough pain in cases of canine OA include poor owner compliance, variable plasma drug levels between doses, natural or exercise induced flare-ups and disease progression.
According to research carried out by the company, veterinary surgeons estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain4, whilst owners put the figure much higher at 80%5.
Animalcare says that as well as compromising patient welfare and increasing the risk of clinical consequences such as wind-up pain (hypersensitisation), breakthrough pain risks owners losing confidence in their vet and/or the recommended treatment plan for their dog. This may lead owners to independently stray from the treatment plan, with potentially damaging consequences. In its research, 87% of vets agreed that avoiding breakthrough pain is critical to the management of canine OA4.
Animalcare adds that because of the pharmacology, there is no risk of risk of over-accumulation or need for mandatory treatment ‘breaks’6. Also, adverse effects were found to be no different from any other NSAID1,2 and there was no increase in treatment-related adverse effects at up to 5 times the recommended dose7, so Daxocox has a broad margin of safety and is well tolerated by dogs7.
James Beaumont, marketing manager at Animalcare said: “Daxocox’s weekly administration of a flavoured tablet addresses some of the challenges of managing canine OA that I’m certain most vets will identify with. Breakthrough pain is a real problem and by being able to provide consistent pain control, in a compliance friendly formulation, Daxocox is a real game changer for canine OA management.
For more information, visit: www.animalcare.co.uk, or contact your local Animalcare territory manager, or Animalcare’s head office on 01904 487687.
References:
Hedgehogs: A Practical Guide for Vets aims to help vets assess sick hedgehogs and administer emergency treatment to stabilise them so they can be transferred to a wildlife rescue centre for specialist care.
Hannah, who has examined and treated more than 1,500 hedgehogs since setting up her sanctuary four years ago, said she also wants to create more awareness that hedgehogs seen during the daytime need urgent help.
She said: “As soon as a hedgehog comes out in the day it is usually a cry for help and they should be taken to the vets or a rescue centre as a matter of urgency.
“I wrote the book to help vets who are more familiar with treating small pets like dogs and cats know what to do if a sick hedgehog is brought to them, and to increase their confidence when treating wildlife.
"There are three simple things that every sick hedgehog needs, which are warmth, fluid and pain relief.”
https://www.facebook.com/p/Hannahs-Hedgehog-Rehabilitation-100070882987122
Dechra Veterinary Products has launched a new online fluid therapy distance-learning course for vets and nurses, to help maximise the potential of its Vetivex® fluids range.
The Fluids Knowledge Programme has been created to provide comprehensive and flexible online CPD for companion animal and equine practitioners. The coursework, which counts for six to eight hours of CPD learning, includes the latest thinking from fluid therapy specialists Dr Ava Firth, Karen Humm and Kevin Corley.
Dechra says the course combines theoretical and practical advice on fluid therapy for both small animals and horses, and can be used for training, as a refresher, and to develop thinking on fluid therapy. Self-assessment questions included within the course allow progress to be monitored throughout.
Gwenda Bason, marketing director for Dechra Veterinary Products, said: "We've spent months of research and development producing this online learning portal for professionals. It will enable vets and nurses to improve their knowledge, understanding and patient care. Being online, users can dip in and out of it as and when their schedules allow and additional costs often associated with CPD learning, such as travel or accommodation costs, are eliminated.
"When practices choose Vetivex, they're not just buying bags of fluid, they're benefitting from our investment in practice education which will improve their understanding of the role and management of fluids."
Dechra estimates the programme is worth around £400 per person, and therefore offers savings of over £3000 in CPD costs for an 8 member practice.
To find out more about the Fluids Knowledge Programme visit www.fluidtherapy.co.uk, or contact Liz Rawlings at Dechra on 01743 441 632.